3227 A phase II trial of ofatumumab for mucosa-associated lymphoid tissue lymphoma (MALT lymphoma) - An interim analysis. (September 2015) - Kiesewetter, B.; Mayerhoefer, M.E.; Dolak, W.; Simonitsch-Klupp, I.; Lukas, J.; Raderer, M.